Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetics of multiple sclerosis.

T Fukazawa1, H Sasaki, S Kikuchi

  • 1Hokuyukai Neurology Hospital, Sapporo, Japan.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|April 12, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Insulin antibody does not cause insulin resistance during glucose clamping in rats.

Diabetes research and clinical practice·1992
Same author

Parental methylation patterns of a transgenic locus in adult somatic tissues are imprinted during gametogenesis.

Development (Cambridge, England)·1992
Same author

Extracellular matrix formation in piecemeal necrosis: immunoelectron microscopic study.

Liver·1992
Same author

Daily energy expenditure in active and inactive persons with spinal cord injury.

Journal of human ergology·1992
Same author

Perivascular fibrosis of muscular pulmonary arteries in chronic obstructive pulmonary disease.

Chest·1992
Same author

Partitioning of pulmonary responses to inhaled methacholine in subjects with asymptomatic asthma.

The American review of respiratory disease·1992
Same journal

Corrigendum to "Ruyiping extract reduces lung metastasis in triple negative breast cancer by regulating macrophage polarization" [Biomed. Pharmacother. 141 (2021) 111883].

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same journal

Microfluidic human liver slices reveal antifibrotic effects of liraglutide via HSC deactivation and ECM remodeling.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same journal

Corrigendum to "Targeting PD-L1 and disrupting Siglec-9 cooperatively potentiate macrophage phagocytosis of breast cancer via a trispecific macrophage engager (TriME)" [Biomed. Pharmacother. 200 (2026), 119609].

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same journal

Targeted attenuation of liver fibrosis using microbubble-enhanced protease-activated receptor 1 chimeric antigen receptor T cells.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same journal

Euphol targets key oncogenic processes and promotes chemoprevention in organoid and In Vivo models of colorectal cancers.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same journal

CAR-T cell therapy and oncolytic viruses: A synergic approach for advanced GI cancers.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
See all related articles

Multiple sclerosis (MS) involves genetic factors, but no single gene is solely responsible. Research suggests a polygenic etiology, with different genes potentially influencing the disease course and presentation.

Area of Science:

  • Neuroimmunology
  • Genetics of neurological disorders

Background:

  • Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system.
  • While environmental factors are implicated, genetic contributions to MS are evident from family studies.
  • The Major Histocompatibility Complex (MHC) shows a weak association, but other genetic factors remain largely unconfirmed.

Purpose of the Study:

  • To explore the genetic underpinnings of Multiple Sclerosis (MS).
  • To investigate the role of candidate genes in MS etiology and pathogenesis.
  • To understand genotype-phenotype interactions in MS.

Main Methods:

  • Review of family studies and genome scans for MS susceptibility loci.
  • Analysis of candidate genes implicated in MS.

Related Experiment Videos

  • Examination of genetic contributions to MS heterogeneity.

    • Main Results:

    • Genome scans indicate that MS susceptibility is polygenic, with no single locus being necessary or sufficient.
    • Previous candidate gene associations have not been consistently confirmed.
    • Evidence suggests that MS is a heterogeneous disorder with varying genetic influences.

    Conclusions:

    • Multiple sclerosis (MS) likely arises from a complex interplay of multiple genes (polygenic etiology).
    • Different genes may contribute to the diverse clinical presentations and disease progression observed in MS patients.
    • Further research into candidate genes is needed to elucidate genotype-phenotype correlations in MS.